Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ilaria Defilippi
Variable but Consistent Pattern of Meningioma 1 Gene (MN1) Expression in Different Genetic Subsets of Acute Myelogenous Leukaemia and Its Potential Use as Marker for Minimal Residual Disease Detection.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Metabolomic Profiling Identifies Pathways Associated With Minimal Residual Disease in Childhood Acute Lymphoblastic Leukaemia
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
FLT3 as a Marker of Minimal Residual Disease: Time to Re-Think?
American Journal of Hematology
Hematology
Synthesis and Biological Evaluation of Dithiocarbamate Esters of Parthenolide as Potential Anti-Acute Myelogenous Leukaemia Agents
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma
British Journal of Haematology
Hematology
BAALC Expression: A Suitable Marker for Prognostic Risk Stratification and Detection of Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia
Blood Cancer Journal
Oncology
Hematology
Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Paediatric B-Cell Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
Strategies for Minimal Residual Disease Detection: Current Perspectives
Blood and Lymphatic Cancer: Targets and Therapy
Short-Term Treatment for Acute Myelogenous Leukaemia.
BMJ
Plasma-Derived Exosomes in Acute Myeloid Leukemia for Detection of Minimal Residual Disease: Are We Ready?
Expert Review of Molecular Diagnostics
Forensic Medicine
Genetics
Pathology
Molecular Medicine
Molecular Biology
